Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine vs Liothyronine in Hypothyroidism
NCT03627611Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Aug 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liothyronine in hypothyroidism, sponsored by Oslo University Hospital. Primary endpoint: Brown adipose tissue activation at 6 months. Started Aug 2018; status: completed.
02
Drugs
liothyronine
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT03627611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03627611.